409 related articles for article (PubMed ID: 29553749)
21. Drug and gene co-delivery systems for cancer treatment.
Yang Z; Gao D; Cao Z; Zhang C; Cheng D; Liu J; Shuai X
Biomater Sci; 2015 Jul; 3(7):1035-49. PubMed ID: 26221938
[TBL] [Abstract][Full Text] [Related]
22. Drug targeting systems for cancer therapy: nanotechnological approach.
Tigli Aydin RS
Mini Rev Med Chem; 2015; 14(13):1048-54. PubMed ID: 25138089
[TBL] [Abstract][Full Text] [Related]
23. Nanodrugs used in cancer therapy.
Kopeckova K; Eckschlager T; Sirc J; Hobzova R; Plch J; Hrabeta J; Michalek J
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2019 Jun; 163(2):122-131. PubMed ID: 30967685
[TBL] [Abstract][Full Text] [Related]
24. Targeted nanomedicine for cancer therapeutics: Towards precision medicine overcoming drug resistance.
Bar-Zeev M; Livney YD; Assaraf YG
Drug Resist Updat; 2017 Mar; 31():15-30. PubMed ID: 28867241
[TBL] [Abstract][Full Text] [Related]
25. Current Perspectives on Novel Drug Delivery Systems and Therapies for Management of Prostate Cancer: An Inclusive Review.
Bhosale RR; Gangadharappa HV; Hani U; Ali M Osmani R; Vaghela R; Kulkarni PK; Koganti VS
Curr Drug Targets; 2017; 18(11):1233-1249. PubMed ID: 27296312
[TBL] [Abstract][Full Text] [Related]
26. Enzyme-triggered nanomedicine: drug release strategies in cancer therapy.
Andresen TL; Thompson DH; Kaasgaard T
Mol Membr Biol; 2010 Oct; 27(7):353-63. PubMed ID: 20939771
[TBL] [Abstract][Full Text] [Related]
27. Recent advances in "smart" delivery systems for extended drug release in cancer therapy.
Kalaydina RV; Bajwa K; Qorri B; Decarlo A; Szewczuk MR
Int J Nanomedicine; 2018; 13():4727-4745. PubMed ID: 30154657
[TBL] [Abstract][Full Text] [Related]
28. Stealth Nanocarriers in Cancer Therapy: a Comprehensive Review of Design, Functionality, and Clinical Applications.
Saadh MJ; Mustafa MA; Kumar A; Alamir HTA; Kumar A; Khudair SA; Faisal A; Alubiady MHS; Jalal SS; Shafik SS; Ahmad I; Khry FAF; Abosaoda MK
AAPS PharmSciTech; 2024 Jun; 25(6):140. PubMed ID: 38890191
[TBL] [Abstract][Full Text] [Related]
29. Advances in combination therapies based on nanoparticles for efficacious cancer treatment: an analytical report.
Mignani S; Bryszewska M; Klajnert-Maculewicz B; Zablocka M; Majoral JP
Biomacromolecules; 2015 Jan; 16(1):1-27. PubMed ID: 25426779
[TBL] [Abstract][Full Text] [Related]
30. Role of integrated cancer nanomedicine in overcoming drug resistance.
Iyer AK; Singh A; Ganta S; Amiji MM
Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1784-802. PubMed ID: 23880506
[TBL] [Abstract][Full Text] [Related]
31. Recent progress in drug delivery systems for anticancer agents.
Kim CK; Lim SJ
Arch Pharm Res; 2002 Jun; 25(3):229-39. PubMed ID: 12135091
[TBL] [Abstract][Full Text] [Related]
32. Recent progress in nanomedicine-based combination cancer therapy using a site-specific co-delivery strategy.
Shen S; Liu M; Li T; Lin S; Mo R
Biomater Sci; 2017 Jul; 5(8):1367-1381. PubMed ID: 28664207
[TBL] [Abstract][Full Text] [Related]
33. Liposomal therapies in oncology: does one size fit all?
Sousa I; Rodrigues F; Prazeres H; Lima RT; Soares P
Cancer Chemother Pharmacol; 2018 Nov; 82(5):741-755. PubMed ID: 30116847
[TBL] [Abstract][Full Text] [Related]
34. Nanomedicine: a new frontier in cancer therapeutics.
Lee PY; Wong KK
Curr Drug Deliv; 2011 May; 8(3):245-53. PubMed ID: 21291378
[TBL] [Abstract][Full Text] [Related]
35. Emerging potential of stimulus-responsive nanosized anticancer drug delivery systems for systemic applications.
Ruttala HB; Ramasamy T; Madeshwaran T; Hiep TT; Kandasamy U; Oh KT; Choi HG; Yong CS; Kim JO
Arch Pharm Res; 2018 Feb; 41(2):111-129. PubMed ID: 29214601
[TBL] [Abstract][Full Text] [Related]
36. Nanomedicines as emerging platform for simultaneous delivery of cancer therapeutics: new developments in overcoming drug resistance and optimizing anticancer efficacy.
Hussain Z; Arooj M; Malik A; Hussain F; Safdar H; Khan S; Sohail M; Pandey M; Choudhury H; Ei Thu H
Artif Cells Nanomed Biotechnol; 2018; 46(sup2):1015-1024. PubMed ID: 29873531
[TBL] [Abstract][Full Text] [Related]
37. Nanomaterial-Enabled Cancer Therapy.
Quader S; Kataoka K
Mol Ther; 2017 Jul; 25(7):1501-1513. PubMed ID: 28532763
[TBL] [Abstract][Full Text] [Related]
38. pH-sensitive nano-systems for drug delivery in cancer therapy.
Liu J; Huang Y; Kumar A; Tan A; Jin S; Mozhi A; Liang XJ
Biotechnol Adv; 2014; 32(4):693-710. PubMed ID: 24309541
[TBL] [Abstract][Full Text] [Related]
39. Light-induced liposomes for cancer therapeutics.
Chen W; Goldys EM; Deng W
Prog Lipid Res; 2020 Jul; 79():101052. PubMed ID: 32679153
[TBL] [Abstract][Full Text] [Related]
40. Influence of nanomedicine mechanical properties on tumor targeting delivery.
Li Z; Xiao C; Yong T; Li Z; Gan L; Yang X
Chem Soc Rev; 2020 Apr; 49(8):2273-2290. PubMed ID: 32215407
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]